Skip to content

Beyond Meat BYND Loss from impairment of long-lived assets

Loss from impairment of long-lived assets at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$0
Alto Ingredients, Inc. logo
Alto Ingredients, Inc.ALTO
$200.75K-96.8%
UBS
United BanksharesUBSI
$13.75K-74.9%
APO
Apogee EnterprisesAPOG
$4.06M-46.8%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$347K
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$0-100%

Other financials

Income statement

See full
Revenue$58.2M-15.3%
Gross profit$2.0M+129%
Operating income-$41.1M+36.1%
Net income-$28.5M+53.4%
EPS (diluted)-$0.06+92.5%

Balance sheet

See full
Cash & equivalents$205.8M+77.6%
Total debt$526.7M-56.9%
Total equity-$21.1M+96.8%
Total assets$579.5M-10.0%

Cash flow

See full
Operating cash flow-$5.0M+80.8%
CapEx$2.5M-43.7%
Free cash flow-$7.6M+75.3%

Valuation

See full
Market cap$352.65M+34.4%
Enterprise value$673.58M-50.8%
P/E1.5×
P/S1.3×+0.5×

Profitability

See full
Gross margin6.5%+3.8pp
Operating margin-120.2%-521pp
Net margin91.9%+67.4pp
FCF margin-50.6%+51.8pp

Returns & leverage

See full
Return on equity-167.4%
Debt / equity28.2×
Current ratio2.9×-0.5×

Where this comes from

Reported directly by Beyond Meat in its filing.

Tagged under the XBRL concept bynd:TangibleAssetImpairmentChargesExcludingAssetsHeldForSaleOperatingActivities.

The official record: Beyond Meat’s 10-K, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beyond Meat's loss from impairment of long-lived assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Beyond Meat's loss from impairment of long-lived assets?
Beyond Meat (BYND) reported loss from impairment of long-lived assets of $12.82M in Q4 2025.
What does loss from impairment of long-lived assets mean?
Represents non-cash charges recognized when the carrying amount of long-lived tangible assets exceeds their fair value. This reflects a downward adjustment in the expected future economic utility of production facilities or equipment. High levels of impairment often signal structural challenges in manufacturing efficiency or shifts in long-term production strategy.